Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT2LY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,652
Award facts
- Contract value 100% obligated
- $31,652.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,652.19 to AmerSourceBergen Drug Corp on January 7, 2026, for the supply of Cosentyx (secukinumab) 300 mg pens in 2 mL formulations. This firm fixed-price, non-set-aside contract has an ultimate completion date of January 8, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication used to treat autoimmune inflammatory conditions, reflecting the Defense Logistics Agency's ongoing need to supply specialized pharmaceuticals to military treatment facilities and veteran healthcare programs.
This delivery order was issued under AmerSourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.999 billion through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare operations worldwide. AmerSourceBergen's selection through open competition underscores its established capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FT2LY?
SPE2DR26FT2LY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FT2LY worth?
The government has obligated $31,652 on SPE2DR26FT2LY.
Is contract SPE2DR26FT2LY an order under another contract?
Yes. SPE2DR26FT2LY is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2LY competed?
The extent of competition for SPE2DR26FT2LY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award